Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Saved in:
| Title: | Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. |
|---|---|
| Authors: | Doebar SC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Slaets L; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Giordano SH; Departments of Health Services Research and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bartlett JM; Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada & University of Edinburgh, Scotland, UK., Tryfonidis K; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Dijkstra NH; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Linderholm B; Department of Oncology, Swedish Association of Breast Oncologists (SABO), Sahlgrenska University Hospital, Gothenburg, Sweden., Benstead K; Department of Oncology, Cheltenham General Hospital, Gloucestershire, UK., Dinjens WN; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Marion R; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., van Deurzen CH; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands. |
| Source: | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2017 Apr; Vol. 30 (4), pp. 509-518. Date of Electronic Publication: 2017 Jan 13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28084333 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Doebar+SC%22">Doebar SC</searchLink>; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Slaets+L%22">Slaets L</searchLink>; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Cardoso+F%22">Cardoso F</searchLink>; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Giordano+SH%22">Giordano SH</searchLink>; Departments of Health Services Research and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Bartlett+JM%22">Bartlett JM</searchLink>; Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada & University of Edinburgh, Scotland, UK.<br /><searchLink fieldCode="AU" term="%22Tryfonidis+K%22">Tryfonidis K</searchLink>; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Dijkstra+NH%22">Dijkstra NH</searchLink>; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schröder+CP%22">Schröder CP</searchLink>; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Asperen+CJ%22">van Asperen CJ</searchLink>; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Linderholm+B%22">Linderholm B</searchLink>; Department of Oncology, Swedish Association of Breast Oncologists (SABO), Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Benstead+K%22">Benstead K</searchLink>; Department of Oncology, Cheltenham General Hospital, Gloucestershire, UK.<br /><searchLink fieldCode="AU" term="%22Dinjens+WN%22">Dinjens WN</searchLink>; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Marion+R%22">van Marion R</searchLink>; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Diest+PJ%22">van Diest PJ</searchLink>; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Martens+JW%22">Martens JW</searchLink>; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Deurzen+CH%22">van Deurzen CH</searchLink>; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228806605%22">Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc</searchLink> [Mod Pathol] 2017 Apr; Vol. 30 (4), pp. 509-518. <i>Date of Electronic Publication: </i>2017 Jan 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8806605 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1530-0285 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208933952%22">08933952 </searchLink><i>NLM ISO Abbreviation: </i>Mod Pathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28084333 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/modpathol.2016.229 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 509 Titles: – TitleFull: Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Doebar SC – PersonEntity: Name: NameFull: Slaets L – PersonEntity: Name: NameFull: Cardoso F – PersonEntity: Name: NameFull: Giordano SH – PersonEntity: Name: NameFull: Bartlett JM – PersonEntity: Name: NameFull: Tryfonidis K – PersonEntity: Name: NameFull: Dijkstra NH – PersonEntity: Name: NameFull: Schröder CP – PersonEntity: Name: NameFull: van Asperen CJ – PersonEntity: Name: NameFull: Linderholm B – PersonEntity: Name: NameFull: Benstead K – PersonEntity: Name: NameFull: Dinjens WN – PersonEntity: Name: NameFull: van Marion R – PersonEntity: Name: NameFull: van Diest PJ – PersonEntity: Name: NameFull: Martens JW – PersonEntity: Name: NameFull: van Deurzen CH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2017 Apr Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1530-0285 Numbering: – Type: volume Value: 30 – Type: issue Value: 4 Titles: – TitleFull: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Type: main |
| ResultId | 1 |